» Articles » PMID: 38175478

An Updated View on the Cellular Uptake and Mode-of-Action of Clostridioides Difficile Toxins

Overview
Date 2024 Jan 4
PMID 38175478
Authors
Affiliations
Soon will be listed here.
Abstract

Research on the human gut pathogen Clostridioides (C.) difficile and its toxins continues to attract much attention as a consequence of the threat to human health posed by hypervirulent strains. Toxin A (TcdA) and Toxin B (TcdB) are the two major virulence determinants of C. difficile. Both are single-chain proteins with a similar multidomain architecture. Certain hypervirulent C. difficile strains also produce a third toxin, namely binary toxin CDT (C. difficile transferase). C. difficile toxins are the causative agents of C. difficile-associated diseases (CDADs), such as antibiotics-associated diarrhea and pseudomembranous colitis. For that reason, considerable efforts have been expended to unravel their molecular mode-of-action and the cellular mechanisms responsible for their uptake. Many of these studies have been conducted in European laboratories. Here, we provide an update on our previous review (Papatheodorou et al. Adv Exp Med Biol, 2018) on important advances in C. difficile toxins research.

Citing Articles

Purified CDT toxins and a clean deletion within the CDT locus provide novel insights into the contribution of binary toxin in cellular inflammation and Clostridioides difficile infection.

Nabukhotna K, Kordus S, Shupe J, Cano Rodriguez R, Smith A, Bohannon J PLoS Pathog. 2024; 20(9):e1012568.

PMID: 39298531 PMC: 11444381. DOI: 10.1371/journal.ppat.1012568.


and Gut Microbiota: From Colonization to Infection and Treatment.

Spigaglia P Pathogens. 2024; 13(8).

PMID: 39204246 PMC: 11357127. DOI: 10.3390/pathogens13080646.


Structural and Functional Insights into the Delivery Systems of and Clostridial Binary Toxins.

Sevdalis S, Varney K, Cook M, Gillespie J, Pozharski E, Weber D Toxins (Basel). 2024; 16(8).

PMID: 39195740 PMC: 11359772. DOI: 10.3390/toxins16080330.


Inhibition of Clostridioides difficile toxins TcdA and TcdB by the amiodarone derivative dronedarone.

Matylitsky J, Krieg A, Schumacher J, Borho J, Barth H, Papatheodorou P Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):9877-9885.

PMID: 38935126 PMC: 11582217. DOI: 10.1007/s00210-024-03248-8.


Overview of Bacterial Protein Toxins from Pathogenic Bacteria: Mode of Action and Insights into Evolution.

Popoff M Toxins (Basel). 2024; 16(4).

PMID: 38668607 PMC: 11054074. DOI: 10.3390/toxins16040182.


References
1.
Aktories K . Bacterial protein toxins that modify host regulatory GTPases. Nat Rev Microbiol. 2011; 9(7):487-98. DOI: 10.1038/nrmicro2592. View

2.
Aktories K, Wegner A . ADP-ribosylation of actin by clostridial toxins. J Cell Biol. 1989; 109(4 Pt 1):1385-7. PMC: 2115792. DOI: 10.1083/jcb.109.4.1385. View

3.
Aktories K, Barmann M, OHISHI I, Tsuyama S, Jakobs K, Habermann E . Botulinum C2 toxin ADP-ribosylates actin. Nature. 1986; 322(6077):390-2. DOI: 10.1038/322390a0. View

4.
Aktories K, Schwan C, Jank T . Clostridium difficile Toxin Biology. Annu Rev Microbiol. 2017; 71:281-307. DOI: 10.1146/annurev-micro-090816-093458. View

5.
Albesa-Jove D, Bertrand T, Carpenter E, Swain G, Lim J, Zhang J . Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS. J Mol Biol. 2010; 396(5):1260-70. DOI: 10.1016/j.jmb.2010.01.012. View